|
|
|
2006 Neurotech Leaders Forum
September 28-29, 2006
Preliminary Agenda
Day One: Neurotech Short Courses
This half-day event is targeted at early-stage neurotechnology firms and research professionals contemplating launching a neurotech start-up. Conference faculty will offer a detailed background on the basics of the neurotechnolgy industry and tutorial courses on preparing a business plan, conducting market and competitive research, and locating sources of funding specific to the neurotechnology industry.
| 12:00-1:00 |
Registration |
| 1:00-2:30 |
Basics of Neurotechnology
Warren Grill, Ph.D, Senior Technical Editor, Neurotech
Reports
In this session, one of the nation's leading experts on neurotechnology, Warren Grill of Duke University, will present a tutorial on the fundamentals of neurostimulation, neuromodulation, deep-brain stimulation, and related topics. The tutorial will explain how neurotech devices work, and include a discussion of product features, stimulation parameters, targeted locations. |
| 2:30-3:00 |
Refreshment Break |
| 3:00-4:00 |
Obtaining Venture Capital Financing
Glenn Cornett, Ph.D, M.D., Senior Financial Editor, Neurotech Reports
This session offers specific and practical advice on preparing a set of initial materials, including executive summary, investor presentation, and financial model, that will attract attention from venture capital firms. It includes examples of items that have made the difference between funding and no funding decisions. The presenter will also discuss how to find the most appropriate VC firm and how to arrange a meeting with the key person at the firm. |
| 4:00-5:00 |
Neurotechnology Market Fundamentals
James Cavuoto, Editor and Publisher, Neurotech Reports
This session gives attendees an overview of the neurotechnology market, with discussion of overall size, market segments, growth rates, competition, and key players. It will also include discussion of the various markets for neurological diseases and disorders. |
| 5:00-7:00 |
Cocktail Reception
|
| |
|
Day Two: Neurotech Industry Sessions
This full-day conference offers an exclusive forum for neurotechnology executives and entrepreneurs to interact with investors, technologists, and potential partners who are working to grow this new industry.
| 8:30-9:00 |
Registration and Coffee |
| 9:00-9:15 |
Introduction |
| 9:15-9:45 |
Keynote Address: Pioneering a New Industry
Skip Cummins, Chairman and CEO, Cyberonics Inc. |
| 9:45-10:15 |
Neurotechnology Industry Update
James Cavuoto, Editor and Publisher, Neurotech Reports
This session will provide attendees with an up-to-date look at the neurotechnology industry, including discussion of deals, merger and acquisition activity, and venture capital funding that has occurred in the last year. |
| 10:15-10:30 |
Coffee Break, sponsored by BalSeal Engineering
|
| 10:30-11:15 |
The M&A Climate for Neurotechnology
Glenn Cornett, Senior Financial Editor, Neurotech Reports, Moderator
Lothar Krinke, Ph.D., Vice President, Business Development, Medtronic Inc.
Roger Guidi, Vice-President, Johnson & Johnson Development Corp.
Jagjit Gill, CEO, Sage Medical Inc.
Todd Whitehurst, M.D., Vice President, Boston Scientific Corp.
This session will explore the current climate for merger and acquisition activity within the neurotechnology industry. Panelsists include representatives from major medical device companies, acquired firms, and M&A specialists.
|
| 11:15-12:00 |
The Clinician's Perspective
James Cavuoto, Editor, Neurotech Reports, Moderator
James Campbell, M.D., Professor of Neurosurgery, Johns Hopkins University School of Medicine
Michael Keith, M.D., Orthopedic Surgeon, Metro Health Medical Center
Evan Rosenfeld, M.D., Physiatrist, Vice President, Medical and Regulatory Affairs, Bioness Inc.
This session will explore the role that medical specialists play in the design, development, and approval of new neurotech devices. Panelists, including clinicians with experience in neurostimulation systems, deep-brain stimulation systems, and neurosensing systems, will offer their wish list of new features and new devices. |
| 12:00-1:30 |
Luncheon
Presentation of 2006 Gold Electrode Awards |
| 1:30-3:00 |
Entrepreneur Panel
Phil Kennedy, M.D., Ph.D., CEO, Neural Signals Inc.
Souhile Assaf, Ph.D., CEO, Medtrode Inc.
David Hable,
CEO, Afferent Corp.
Daniel DiLorenzo, M.D., Ph.D., Founder, BioNeuronics Corp.
Alvaro Fernandez, Managing Director, SharpBrains Inc.
This session features presentations from CEOs and executives of several neurotechnology start-up firms and more established technology ventures. Each executive will present an overview of their firm's technology and markets. |
| 3:00-3:15 |
Refreshment Break, sponsored by Greatbatch Inc. |
| 3:15-4:00 |
New Technologies Panel
Warren Grill, Ph.D., Senior Technical Editor, Neurotech Reports, Moderator
Ted Berger, Ph.D., Director, USC Center for Neural Engineering
Daniel DiLorenzo, Ph.D., M.D., Founder, BioNeuronics Corp.
Joe Pancrazio Ph.D., Program Director, National Institutes of Health
This session looks at several new technology areas within the field of neurotechnology and explores the commercialization potential of each. Technologies covered include deep brain stimulation, brain-computer interfaces, magnetic stimulation systems, nanobiotechnology applications, and biomimetic microelectronics. |
| 4:00-5:00 |
Venture Capital Firms Perspective
James Cavuoto, Editor, Neurotech Reports, Moderator
Paul Grand, Director, RCT
BioVentures
Michael Goldberg, General Partner, Mohr, Davidow Ventures
Ellen Koskinas, Partner, InterWest Partners
In this wrap-up session, representatives from several key venture capital firms in the life sciences space will offer their feedback on the status of the neurotechnology industry and their impressions of the issues discussed during the day. |
| 5:00-7:00 |
Cocktail Reception, sponsored by Cyberonics |
| |
|
|
